KAYLEE WIENS: Open Payments
NPI 1871321687 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 72 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $194 · 2025 $1,268
Food & beverage: $1,184Education: $84
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $217 |
| ABBVIE INC. | 13 | $176 |
| Janssen Biotech, Inc. | 7 | $172 |
| Lilly USA, LLC | 11 | $137 |
| Ardelyx, Inc. | 5 | $99 |
| Aimmune Therapeutics, Inc. | 3 | $72 |
| Ipsen Biopharmaceuticals, Inc | 4 | $68 |
| Gilead Sciences, Inc. | 3 | $65 |
| GENZYME CORPORATION | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
Products named: ENTYVIO, TREMFYA, OMVOH, IBSRELA, ZENPEP, IQIRVO, DUPIXENT, LINZESS.
Industry payments across KS — which companies pay providers there.
